Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Oct 16, 2017 7:00am EDT

Heat Biologics Announces Pricing for Rights Offering to Stockholders and Participating Warrant Holders

Oct 12, 2017 7:00am EDT

UPDATE: Heat Biologics to Present at the Upcoming BIO Investor Forum in San Francisco

Sep 28, 2017 7:00am EDT

Heat Biologics Announces Expected Calendar for Rights Offering

Sep 27, 2017 7:00am EDT

Pelican Therapeutics Announces Manufacturing Agreement with KBI Biopharma to Advance Cancer-targeting Immunotherapies

Sep 15, 2017 7:10am EDT

Heat Biologics Announces Common Stock Rights Offering in Form S-1 Filing

Sep 12, 2017 7:00am EDT

Heat Biologics Granted Type C Meeting with FDA to Discuss Registrational Pathway for HS-110 in Combination with Opdivo(R) as a Treatment for Non-Small Cell Lung Cancer

Sep 07, 2017 7:00am EDT

Heat Biologics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

Aug 14, 2017 7:04am EDT

Heat Biologics Inc. Reports Second Quarter 2017 Results

Jul 03, 2017 7:00am EDT

Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics

Jul 03, 2017 7:00am EDT

Heat Biologics Appoints Damien Hallet as Vice President of CMC Development

rss_feed News RSS